The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Open accessAbstract
Studies of the pathogenesis and molecular biology of JC virus infection over the last two decades have significantly changed our understanding of progressive multifocal leukoencephalopathy, which can be described as a subacute viral infection of neuroglial cells that probably follows reactivation of latent infection rather than being the consequence of prolonged JC virus replication in the brain. There is now sufficient evidence to suggest that JC virus latency occurs in kidney and B cells. However, JC virus isolates from brain or kidney differ in the regulatory regions of their viral genomes which are controlled by host cell factors for viral gene expression and replication. DNA sequences of noncoding regions of the viral genome display a certain heterogeneity among isolates from brain and kidney. These data suggest that an archetypal strain of JC virus exists whose sequence is altered during replication in different cell types. The JC virus regulatory region likely plays a significant role in establishing viral latency and must be acted upon for reactivation of the virus. A developing hypothesis is that reactivation takes place from latently infected B lymphocytes that are activated as a result of immune suppression. JC virus enters the brain in the activated B cell. Evidence for this mechanism is the detection of JC virus DNA in peripheral blood lymphocytes and infected B cells in the brains of patients with progressive multifocal leukoencephalopathy. Once virus enters the brain, astrocytes as well as oligodendrocytes support JC virus multiplication. Therefore, JC virus infection of neuroglial cells may impair other neuroglial functions besides the production and maintenance of myelin. Consequently our increased understanding of the pathogenesis of progressive multifocal leukoencephalopathy suggests new ways to intervene in JC virus infection with immunomodulation therapies. Perhaps along with trials of nucleoside analogs or interferon administration, this fatal disease, for which no consensus of antiviral therapy exists, may yield to innovative treatment protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1979 xxxvi + 1388 pages. $120.00
Cavalier-Smith, T. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80323-1 · Cited by 6,273
CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY
Padgett, B., Zurhein, G., Walker, D., Eckroade, R., & Dessel, B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91777-6 · Cited by 1,624
NEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATION
Gardner, S., Field, A., Coleman, D., & Hulme, B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91776-4 · Cited by 1,497
ÅSTRÖM, K.-E., MANCALL, E. L., & RICHARDSON, E. P. (1958) · Brain · doi:10.1093/brain/81.1.93 · Cited by 832
Cellular immune reactivity within the CNS
Wekerle, H., Linington, C., Lassmann, H., & Meyermann, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90077-9 · Cited by 768
A multiplicity of CCAAT box-binding proteins
Dorn, A., Bollekens, J., Staub, A., Benoist, C., & Mathis, D. (1987) · Cell · doi:10.1016/0092-8674(87)90513-7 · Cited by 709
Human polyomavirus JC virus genome
Frisque, R. J., Bream, G. L., & Cannella, M. T. (1984) · Journal of Virology · doi:10.1128/jvi.51.2.458-469.1984 · Cited by 675
Human CCAAT-binding proteins have heterologous subunits
Chodosh, L. A., Baldwin, A. S., Carthew, R. W., & Sharp, P. A. (1988) · Cell · doi:10.1016/0092-8674(88)90483-7 · Cited by 658
Progressive Multifocal Leukoencephalopathy
Richardson, E. P. (1961) · New England Journal of Medicine · doi:10.1056/nejm196110262651701 · Cited by 611
Cited by
Carson, K. R., Evens, A. M., Richey, E. A., Habermann, T. M., Focosi, D., Seymour, J. F., Laubach, J., Bawn, S. D., Gordon, L. I., Winter, J. N., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186999 · Cited by 866
Self-citationNistor, G. I., Totoiu, M. O., Haque, N., Carpenter, M. K., & Keirstead, H. S. (2005) · Glia · doi:10.1002/glia.20127 · Cited by 580
Carson, K. R., Focosi, D., Major, E. O., Petrini, M., Richey, E. A., West, D. P., & Bennett, C. L. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70161-5 · Cited by 447
Self-citationNatalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
Kappos, L., Bates, D., Hartung, H.-P., Havrdova, E., Miller, D., Polman, C. H., Ravnborg, M., Hauser, S. L., Rudick, R. A., Weiner, H. L., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70078-9 · Cited by 421
Self-citationA cornucopia of human polyomaviruses
DeCaprio, J. A., & Garcea, R. L. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2992 · Cited by 363
THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Narayana, P. A., Doyle, T. J., Lai, D., & Wolinsky, J. S. (1998) · Annals of Neurology · doi:10.1002/ana.410430112 · Cited by 318
CNS Infection and Immune Privilege
Forrester, J. V., McMenamin, P. G., & Dando, S. J. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0070-8 · Cited by 313
Monaco, M. C., Atwood, W. J., Gravell, M., Tornatore, C. S., & Major, E. O. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7004-7012.1996 · Cited by 293
Self-citationThe role of polyomaviruses in human disease
Jiang, M., Abend, J. R., Johnson, S. F., & Imperiale, M. J. (2009) · Virology · doi:10.1016/j.virol.2008.09.027 · Cited by 293
Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Clifford, D. B., Ances, B., Costello, C., Rosen-Schmidt, S., Andersson, M., Parks, D., Perry, A., Yerra, R., Schmidt, R., Alvarez, E., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.103 · Cited by 278
Functional signatures of protective antiviral T‐cell immunity in human virus infections
Harari, A., Dutoit, V., Cellerai, C., Bart, P., Du Pasquier, R. A., & Pantaleo, G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00395.x · Cited by 273
JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy
Koralnik, I. J., Boden, D., Mai, V. X., Lord, C. I., & Letvin, N. L. (1999) · Neurology · doi:10.1212/wnl.52.2.253 · Cited by 256
A Review of Therapeutic Uses of Mirtazapine in Psychiatric and Medical Conditions
Alam, A., Voronovich, Z., & Carley, J. A. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01525 · Cited by 84
Opportunistic infections in patients with cancer
Klastersky, J., & Aoun, M. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh947 · Cited by 72
Metadata
- Authors
- Major, E. O., Amemiya, K., Tornatore, C. S., Houff, S. A., & Berger, J. R.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1992-01
- Volume
- 5
- Issue
- 1
- Pages
- 49-73
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1943449996
- Cited by
- 535
- References
- 68
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.